Bellicum Pharmaceuticals (NASDAQ:BLCM) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 14.9 % Shares of BLCM stock opened at $0.15 on Monday. The firm’s 50 day moving average price is […]
More Stories
Integrated Investment Consultants LLC Acquires Shares of 1,840 The Trade Desk, Inc. (NASDAQ:TTD)
Integrated Investment Consultants LLC bought a new position in The Trade Desk, Inc. (NASDAQ:TTD – Free Report) during the third...
Navellier & Associates Inc. Purchases New Position in Fortinet, Inc. (NASDAQ:FTNT)
Navellier & Associates Inc. bought a new stake in shares of Fortinet, Inc. (NASDAQ:FTNT – Free Report) during the 3rd...
Integrated Investment Consultants LLC Has $242,000 Position in Apollo Global Management, Inc. (NYSE:APO)
Integrated Investment Consultants LLC trimmed its stake in Apollo Global Management, Inc. (NYSE:APO – Free Report) by 34.0% in the...
Banco Santander S.A. Acquires 18,089 Shares of ZTO Express (Cayman) Inc. (NYSE:ZTO)
Banco Santander S.A. grew its stake in shares of ZTO Express (Cayman) Inc. (NYSE:ZTO – Free Report) by 80.4% during...
Liberty Energy Inc. (NYSE:LBRT) Receives $22.89 Consensus Target Price from Brokerages
Liberty Energy Inc. (NYSE:LBRT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven...
Integrated Investment Consultants LLC Grows Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Integrated Investment Consultants LLC lifted its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 48.4% in...